Fludarabine Phosphate

Form: Injection (IV), Oral Tablet

Strength: Injection: 25 mg/ml; Tablet: 10 mg

Reference Brands: Fludara® (US & EU)

Category: Oncology Cancer Care

Fludarabine Phosphate is a widely used oncology medication indicated for chronic lymphocytic leukemia (CLL) and certain non-Hodgkin’s lymphomas. It is available in the US and EU as a 25 mg/mL injection and 10 mg oral tablets. Marketed under the brand name Fludara® and as generics, Fludarabine Phosphate is a purine analog that interferes with DNA synthesis, promoting apoptosis in malignant cells. It is a critical chemotherapy option in hematologic cancer protocols and widely used in hospital oncology units and pharma B2B distribution. Its established efficacy and regulatory approval make it a trusted choice across global markets.